Page last updated: 2024-11-02

pd 169316 and Bone Loss, Osteoclastic

pd 169316 has been researched along with Bone Loss, Osteoclastic in 1 studies

2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karsdal, MA1
Fjording, MS1
Foged, NT1
Delaissé, JM1
Lochter, A1

Other Studies

1 other study available for pd 169316 and Bone Loss, Osteoclastic

ArticleYear
Transforming growth factor-beta-induced osteoblast elongation regulates osteoclastic bone resorption through a p38 mitogen-activated protein kinase- and matrix metalloproteinase-dependent pathway.
    The Journal of biological chemistry, 2001, Oct-19, Volume: 276, Issue:42

    Topics: 3T3 Cells; Animals; Blotting, Western; Bone Resorption; Cell Division; Cell-Free System; Cells, Cult

2001